These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 15194146
1. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S. J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146 [Abstract] [Full Text] [Related]
2. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. Shimada Y, Takehara K, Sato S. J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590 [Abstract] [Full Text] [Related]
3. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases. Echigo T, Hasegawa M, Shimada Y, Inaoki M, Takehara K, Sato S. Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210 [Abstract] [Full Text] [Related]
6. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K, Takehara K, Sato S. Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972 [Abstract] [Full Text] [Related]
8. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides. Shimauchi T, Sugita K, Nishio D, Isoda H, Abe S, Yamada Y, Hino R, Ogata M, Kabashima K, Tokura Y. J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665 [Abstract] [Full Text] [Related]
9. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus. Okamoto H, Koizumi K, Yamanaka H, Saito T, Kamatani N. J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179 [Abstract] [Full Text] [Related]
11. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S. J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017 [Abstract] [Full Text] [Related]
13. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology. Quaglino P, Caproni M, Antiga E, Del Bianco E, Osella-Abate S, Savoia P, Frezzolini A, Schena D, Marzano A, Volpi W, De Simone C, Parodi A, Fabbri P, Bernengo MG, Italian Group of Immunopathology. Dermatology; 2007 Apr; 214(4):296-304. PubMed ID: 17460400 [Abstract] [Full Text] [Related]
15. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. Hammad H, Smits HH, Ratajczak C, Nithiananthan A, Wierenga EA, Stewart GA, Jacquet A, Tonnel AB, Pestel J. Eur Cytokine Netw; 2003 Apr; 14(4):219-28. PubMed ID: 14715413 [Abstract] [Full Text] [Related]
16. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. Nishijima C, Sato S, Takehara K. J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588 [Abstract] [Full Text] [Related]
17. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. Bochner BS, Hudson SA, Xiao HQ, Liu MC. J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482 [Abstract] [Full Text] [Related]
18. Elevated circulating CD40L concentrations in patients with systemic sclerosis. Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. J Rheumatol; 2004 Mar; 31(3):514-9. PubMed ID: 14994397 [Abstract] [Full Text] [Related]